Here is the link to the information regarding the CVR (Contingent Value Rights) as filed with the SEC: https://www.sec.gov/Archives/edgar/data/0001460702/000149315220000828/ex2-2.htm
Recent QLGN News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:23:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 10:10:25 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/19/2025 10:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 11:10:26 AM
- Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy • GlobeNewswire Inc. • 11/16/2025 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 10:16:14 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 11/13/2025 02:33:07 AM
- Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025 • GlobeNewswire Inc. • 10/28/2025 03:57:00 AM
- Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation • GlobeNewswire Inc. • 10/23/2025 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2025 09:20:05 PM
- Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? • GlobeNewswire Inc. • 10/13/2025 01:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/10/2025 09:15:09 PM
- Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition • GlobeNewswire Inc. • 10/06/2025 11:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 09:27:31 PM
- Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI) • GlobeNewswire Inc. • 09/30/2025 08:00:00 PM
- Qualigen Therapeutics shares spike after securing $41M PIPE financing • IH Market News • 09/30/2025 12:11:59 PM
- Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto • GlobeNewswire Inc. • 09/30/2025 11:08:31 AM
- Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy • GlobeNewswire Inc. • 09/30/2025 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2025 10:04:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2025 09:05:45 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/24/2025 08:28:59 PM
- Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction • GlobeNewswire Inc. • 09/19/2025 11:24:37 PM
- Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction • GlobeNewswire Inc. • 09/19/2025 10:01:00 PM
